News
U.S. funded treatments in the country have helped reduce deaths from HIV/AIDS to around 14,000 a year, from as high as ...
A recent study shows a substantial decline in the use of nonrecommended antiviral prescriptions among Medicare beneficiaries ...
As the federal government moves forward with steep cuts to medical and research funding, some in the Bay Area who depend on ...
10m
LGBTQ Nation on MSNHIV Awareness still belongs at the heart of Pride MonthToday, Pride is still an uprising. Keeping HIV awareness and prevention at the heart of Pride Month deepens its mission and ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
Experts warn that the surge in HIV cases among Filipino youth is being driven by policy gaps, inadequate sex education and a ...
Their approach is deeply community-based: going where young people are, whether that’s a barangay gym, a classroom, or even an open shed ...
It took several bids and months of back-and-forth negotiations, but CDMO Future Pak finally secured its long-sought buyout of HIV-focused drugmaler Theratechnologies. | Future Pak's most recent bid ...
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
HIV Testing Atlanta took center stage on Thursday, June 26, as Streetz 94.5 and rolling out magazine joined forces with the ...
Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.
HALIFAX, NS / ACCESS Newswire / July 7, 2025 / MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results